CIK 0001789972
- Non-accelerated filer
- Smaller reporting company
Cullinan Therapeutics, Inc.
Sign in to watch- Ticker
- CGEM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813879991
- Phone
- +1 617-410-4650
- Business address
- ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
- Former names
- Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
- 4 Grant or award Chief Development Officer acquired 1,620 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,451 shares (grant or award)
- 4 Grant or award President and CEO acquired 1,620 shares (grant or award)
- 4 Exercise or conversion 10% owner acquired 140,374 shares (option exercise)
- 4 Open-market sale 10% owner sold 101,903 shares at an average $12.80 ($1,304,816)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 8,090 shares at $12.40 ($100,316)
- 4 Open-market buy 10% owner bought 751,396 shares at $11.00 ($8,264,905)
- 4 Open-market sale 10% owner sold 418,738 shares at an average $9.66 ($4,045,791)
- 4 Open-market buy 10% owner bought 1,109,900 shares at an average $9.07 ($10,063,937)
- 4 Open-market buy 10% owner bought 276,000 shares at $10.75 ($2,966,972)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 13 · 253 filings